REGN · NASDAQ · Biotechnology

Regeneron (REGN)

Develops antibody and genetic medicines led by Dupixent, EYLEA HD, and Libtayo.

$795.72
vs last close−8.18 (−1.02%)

Dividend yield
0.46%
Next ex-date
Nov 18, 26
estimated · in 56 days
Annual dividend
$3.70
per share
Schedule
Quarterly
4 payments a year

Per share, Feb 2025 to Aug 2026DividendAnnual yield

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26
Dividend$0.88$0.88$0.88$0.88$0.94$0.94$0.94
Annual yield0.13%0.29%0.46%0.48%0.46%0.56%0.46%
Ex-dateFeb 20May 20Aug 18Nov 20Feb 20May 20Aug 18
Payment dateMar 20Jun 6Sep 3Dec 5Mar 5Jun 4Aug 31

7 payments since Feb 2025

Ex-dateRecordPaidAmountNote
Aug 18, 2026Aug 18, 2026Aug 31, 2026$0.94
May 20, 2026May 20, 2026Jun 4, 2026$0.94
Feb 20, 2026Feb 20, 2026Mar 5, 2026$0.94raised from $0.88
Nov 20, 2025Nov 20, 2025Dec 5, 2025$0.88
Aug 18, 2025Aug 18, 2025Sep 3, 2025$0.88
May 20, 2025May 20, 2025Jun 6, 2025$0.88
Feb 20, 2025Feb 20, 2025Mar 20, 2025$0.88